Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-06

FDA Approved: NIFEDIPINE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for nifedipine from Ascend Laboratories, LLC, updating the existing nifedipine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)

Snippet

SUPPL AP for NIFEDIPINE (NIFEDIPINE)